openPR Logo
Press release

Global Serological Test for Influenza Disease Diagnostics Market is projected to reach the value of $1.41 Billion by 2030.

10-14-2025 01:33 PM CET | Health & Medicine

Press release from: Virtue Market Research

Global Serological Test for Influenza Disease Diagnostics

According to the report published by Virtue Market Research In 2024, the Global Serological Test for Influenza Disease Market was valued at $0.8 Billion, and is projected to reach a market size of $1.41 Billion by 2030. Over the forecast period of 2025-2030, market is projected to grow at a CAGR of 7.3%.

Request Sample Copy of this Report @https://virtuemarketresearch.com/report/serological-test-for-influenza-disease-diagnostics-market/request-sample

The global serological test for influenza disease market has seen significant growth over the years, driven by various factors. One of the long-term market drivers is the increasing prevalence of influenza worldwide. Influenza is a highly contagious respiratory illness that can lead to severe complications, especially in vulnerable populations such as the elderly and young children. As a result, there is a growing demand for serological tests that can accurately detect influenza infections and help healthcare providers diagnose and treat patients effectively.

The COVID-19 pandemic has also had a significant impact on the market. The pandemic has heightened awareness about the importance of testing for infectious diseases, including influenza. This has led to an increased demand for serological tests for influenza, as healthcare systems around the world seek to better understand and manage the spread of respiratory illnesses.

In the short term, one of the key market drivers is the development of innovative serological tests for influenza. These tests are designed to provide faster and more accurate results, enabling healthcare providers to diagnose and treat patients more effectively. Additionally, there is a growing opportunity in the market for point-of-care testing for influenza. Point-of-care tests are designed to be used in clinical settings, such as doctor's offices and emergency rooms, and can provide results in a matter of minutes, allowing for quicker diagnosis and treatment.

One trend that has been observed in the industry is the increasing adoption of digital technologies in serological testing for influenza. Digital technologies, such as mobile apps and cloud-based platforms, are being used to streamline the testing process, improve data management, and enhance communication between healthcare providers and patients. This trend is expected to continue as the industry looks for ways to improve the efficiency and effectiveness of serological testing for influenza.

Segmentation Analysis:
The global Serological Test for Influenza Disease Market segmentation includes:
By Influenza Type: Type A, Type B, Type C.
The largest segment in the Global Serological Test for Influenza Disease Diagnostics Market is Type A influenza. This segment is characterized by its widespread prevalence and the significant impact it has on public health. Type A influenza viruses are known to cause flu pandemics, which are global outbreaks of a new influenza virus that spreads easily from person to person and can cause severe illness.

The fastest-growing segment in the market is also Type A influenza. This growth is driven by increasing awareness of the importance of influenza testing, especially in light of the COVID-19 pandemic. The development of new and improved serological tests for Type A influenza, as well as the adoption of point-of-care testing technologies, are expected to contribute to the growth of this segment.

By End-Use: Hospitals, POCT, Laboratories.
The largest segment in the Global Serological Test for Influenza Disease Diagnostics Market based on end-use is the hospital segment. In 2022, this segment held the primary income share with 42.3%. Seasonal influenza often leads to a large number of hospitalizations, highlighting the potential severity of the disease. Influenza can worsen existing health conditions or lead to the development of other complications that require hospitalization. For example, in 2021-22, about 58.3% of patients hospitalized for flu in the U.S. had hypertension conditions, 44% had cardiovascular diseases, and 40.6% had pregnancy complications. This underscores the importance of hospital treatment for influenza patients.

The fastest-growing segment is point-of-care testing (POCT). Emerging technologically advanced flu diagnostics tests, including the integration of POCT and flu testing, are expected to ease the surveillance process among the geriatric population. Additionally, POCT is predicted to expand flu testing in rural areas of the Asia Pacific regions, where access to healthcare is limited.
Read More @https://virtuemarketresearch.com/report/serological-test-for-influenza-disease-diagnostics-market

Regional Analysis:
The largest segment in the Global Serological Test for Influenza Disease Diagnostics Market by region is North America, which accounted for the predominant income share of 32.9% in 2022. This region is expected to continue its dominant role over the forecast period, driven by growing government surveillance and the presence of key players.

The fastest-growing segment is Asia-Pacific, with the region witnessing the quickest CAGR in the forecasted period. This growth is primarily driven by India and China, where key growth determinants include a large patient pool, improving government collaborations, and enhancement in healthcare infrastructure. Various South-East Asia-Pacific regions have collaborated with global organizations, such as WHO, to tackle the challenges. The most common challenges experienced by the region are a lack of flu-positive samples, low representatives to collect the specimens, and the situation to ship the samples.

Latest Industry Developments:
1. Expansion of Product Portfolio: Companies in the Global Serological Test for Influenza Disease Diagnostics Market are increasingly focusing on expanding their product portfolios to include a wide range of serological tests for influenza. This trend is driven by the need to cater to different market segments and offer solutions that meet the specific needs of healthcare providers and patients. Recent developments include the launch of new serological tests that offer improved accuracy, sensitivity, and ease of use.

2. Strategic Collaborations and Partnerships: Another key trend in the market is the strategic collaborations and partnerships between companies to enhance their market share. These collaborations often involve sharing resources, expertise, and technology to develop innovative serological tests and expand market reach. Recent examples include partnerships between diagnostic companies and research institutions to develop advanced diagnostic solutions for influenza.

3. Focus on Emerging Markets: Companies are increasingly focusing on emerging markets, particularly in Asia-Pacific and Latin America, to enhance their market share. These regions offer significant growth opportunities due to the increasing prevalence of influenza and improving healthcare infrastructure. Companies are establishing local partnerships and distribution networks to better serve these markets and gain a competitive edge.

customize the Full Report Based on Your Requirements @ https://virtuemarketresearch.com/report/serological-test-for-influenza-disease-diagnostics-market/customization

CONTACT US :
Virtue Market Research
Kumar Plaza, #103, SRPF Rd, Ramtekadi, Pune, Maharashtra 411013, India
E-mail: megha@virtuemarketresearch.com
Phone: +1-917 436 1025

ABOUT US :
Virtue Market Research is a strategic management firm helping companies to tackle most of their strategic issues and make informed decisions for their future growth. We offer syndicated reports and consulting services. Our reports are designed to provide insights on the constant flux in the global demand-supply gap of markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Serological Test for Influenza Disease Diagnostics Market is projected to reach the value of $1.41 Billion by 2030. here

News-ID: 4223329 • Views:

More Releases from Virtue Market Research

Global Prostate Cancer Testing Kits Market is projected to reach the value of $7.74 Billion by 2030.
Global Prostate Cancer Testing Kits Market is projected to reach the value of $7 …
According to the report published by Virtue Market Research In 2024, the Global Prostate Cancer Testing Kits Market was valued at $3.21 Billion, and is projected to reach a market size of $7.74 Billion by 2030. Over the forecast period of 2025-2030, market is projected to grow at a CAGR of 13.4%. Request Sample Copy of this Report @https://virtuemarketresearch.com/report/prostate-cancer-testing-kits-market/request-sample In the realm of healthcare, the Global Prostate Cancer Testing Kits
Global Workplace Innovation Platform Market is projected to reach the value of $ 30.44 Billion by 2030
Global Workplace Innovation Platform Market is projected to reach the value of $ …
According to the report published by Virtue Market Research in 2024, the Global Workplace Innovation Platform Market was valued at $ 16.45 Billion, and is projected to reach a market size of $ 30.44 Billion by 2030. Over the forecast period of 2025-2030, market is projected to grow at a CAGR of 10.8 %. Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/workplace-innovation-platform-market/request-sample The global workplace innovation platform market has experienced substantial
Global Wellness & Prevention Connected Health Devices Market is projected to reach the value of $189.10 Billion by 2030
Global Wellness & Prevention Connected Health Devices Market is projected to rea …
According to the report published by Virtue Market Research in 2024, the Global Wellness & Prevention Connected Health Devices Market was valued at $74.43 Billion, and is projected to reach a market size of $189.10 Billion by 2030. Over the forecast period of 2025-2030, market is projected to grow at a CAGR of 20.5 %. Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/wellness-prevention-connected-health-devices-market/request-sample The Global Wellness & Prevention Connected
Global Tortilla Machine Market is projected to reach the value of $ 54.66 Billion by 2030
Global Tortilla Machine Market is projected to reach the value of $ 54.66 Billio …
According to the report published by Virtue Market Research in 2024, the Global Tortilla Machine Market was valued at $39.75 Billion, and is projected to reach a market size of $ 54.66 billion by 2030. Over the forecast period of 2025-2030, market is projected to grow at a CAGR of 5.45%. Request Sample Copy of this Report @ https://virtuemarketresearch.com/report/tortilla-machine-market/request-sample The tortilla machine market is shaped by numerous factors, both long-term and

All 5 Releases


More Releases for Influenza

Multivalent Influenza Vaccines Market Advancing Influenza Prevention Strategies …
The "Multivalent Influenza Vaccines Market" research report represents major insights on the current growth dynamics as well as the primary revenue generation elements that are available in the Multivalent Influenza Vaccines industry along with various other factors over the predicted period 2024-2030. The report on the Multivalent Influenza Vaccines market is focusing on a series of parameters including top manufacturing strategies, industry share, prime opportunities, industrial channels, profit margin, etc.
Influenza Diagnostics Market - Rapid Detection, Effective Protection: Influenza …
Newark, New Castle, USA: The "Influenza Diagnostics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Influenza Diagnostics Market: https://www.growthplusreports.com/report/influenza-diagnostics-market/8780 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Fight off the influenza virus with effective and r …
Newark, New Castle, USA: The "Influenza Medication Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Influenza Medication Market: https://www.growthplusreports.com/report/influenza-medication-market/7859 This latest report researches the industry structure, sales, revenue,
Influenza Medication Market - Revolutionizing Flu Treatment: Innovating Advanced …
Newark, New Castle, USA - new report, titled Influenza Medication Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Medication market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Medication market. The report offers an overview of the market, which
Influenza Vaccines Market - Empowering Strength, Nurturing Immunity: Innovating …
Newark, New Castle, USA - new report, titled Influenza Vaccines Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Influenza Vaccines market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Influenza Vaccines market. The report offers an overview of the market, which
H1N1 Influenza (Swine Influenza) Market to Witness Growth by 2032, Estimates Del …
DelveInsight's "H1N1 Influenza (Swine Influenza) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of H1N1 Influenza (Swine Influenza), historical and forecasted epidemiology as well as the H1N1 Influenza (Swine Influenza) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The H1N1 Influenza (Swine Influenza) market report provides current treatment practices, emerging drugs, the market share of the individual therapies,